Stay updated on DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.

Latest updates to the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedAdded Fallopian Tube Cancer to the Conditions section and added Genetic and Rare Diseases Information Center to the Resources.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page shows a minor site maintenance update: a new Revision: v3.4.2 was added and older notices (including the funding lapse notice and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding status notice indicating potential delays and open NIH facilities; updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe changes are minor UI and metadata updates, including the addition of a glossary toggle and new QC-related fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) and the removal of older QC labels and data references (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no user-visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section added with study sites across California, Georgia, New York, Oregon, Pennsylvania, Texas, Alberta, Ontario, and Quebec. Page revision updated to v3.3.3.SummaryDifference1%

Stay in the know with updates to DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.